Sverrild A, Cerps S, Nieto-Fontarigo JJ, Ramu S, et al. Tezepelumab decreases airway epithelial IL-33 and T2-inflammation in response to viral stimulation in patients with asthma. Allergy 2023 Oct 17. doi: 10.1111/all.15918.
PMID: 37846599